Gevorg Tamamyan: We Can Do More…
FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer
How Sir Cliff Richard Beat Prostate Cancer at 85 and Why He’s Calling for National Screening
FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer
David OMalley: Promising Results From GOG 3026 Trial in Low-Grade Serous Ovarian Cancer
Servier Pharmaceuticals Welcomes Servier México Team to U.S. Office to Advance Strategic Alignment
Ankyra Therapeutics Appoints Sailaja Battula, PhD, as Chief Scientific Officer
SPCC Launches On Demand CME Webinars for the Definitive Trial Project
The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO), focused on accelerating the delivery of life-changing anticancer […]
The EACR conference on The Tumour Ecosystem: From Mechanisms to Novel Therapeutics will be held from 17 to 19 March 2026 in Bergamo, Italy. Organized by the European Association for Cancer Research (EACR), the event's venue is the Centro Congressi Giovanni XXIII. The conference will focus on the latest research in the tumor microenvironment, covering how cancer […]
The "From Protocol to Publication: A Practical Course in Clinical Research" is an exclusive, in-person training event organized by the European School of Oncology (ESO). Scheduled for 17 to 18 March 2026 in Milan, Italy, this advanced, two-day workshop is reserved only for the ten members of the ESO College who achieve the highest scores […]
The 38th TROG Annual Scientific Meeting (ASM), hosted by the Trans-Tasman Radiation Oncology Group (TROG) Cancer Research, will be held in Melbourne from March 17 to 20, 2026. The conference theme is "Driving Intelligent Trials," which focuses on using smarter designs, AI-driven insights, and stronger trial systems to achieve better research outcomes in radiation oncology. […]
The ICHNO 2026, the 10th International Congress on Innovative Approaches in Head and Neck Oncology, will be held from 19–21 March 2026 in Seville, Spain, under the theme: “Driven by Biology, Centred on the Person.” This unique event—jointly organized by ESTRO, EHNS, and ESMO—will bring together the full spectrum of multidisciplinary expertise to explore the […]
The ANZGOG 2026 Annual Scientific Meeting is a flagship event of the Australian New Zealand Gynaecological Oncology Group (ANZGOG). The 2026 ASM, themed "On the Edge: Translating Innovation into Action," is scheduled for March 25–27, 2026, on the Gold Coast, Queensland. It serves as a dynamic forum for national and international experts - including gynaecological […]
The 2026 SITC Spring Scientific: Enhancing Cellular Therapies with Next-generation IO Molecules will be held from March 25–27, 2026, in a hybrid format with options to attend in Tucson, Arizona, or virtually. Organized by the Society for Immunotherapy of Cancer (SITC), the program will bring together experts in cell therapy, drug development, and immuno-oncology to […]
The European Lung Cancer Congress (ELCC 2026) will take place from 25–28 March 2026 in Copenhagen, Denmark, bringing together leading multidisciplinary societies dedicated to thoracic oncology. This congress serves as a key platform for advancing science, sharing education, and enhancing lung cancer care practices globally. With a comprehensive programme designed for medical oncologists, radiation oncologists, […]
The ESTRO course on Stereotactic Radiotherapy and Radiosurgery for Brain Metastases and Skull Base Lesions will take place in Rome, Italy, from March 26–28, 2026. `Directed by Maximilian Niyazi, this course is designed to allow radiation oncologists, medical physicists, radiation therapists, and other specialists to deepen their expertise and master advanced SRS/SRT techniques specifically for treating […]
The 23rd Annual Meeting of the Japanese Society of Medical Oncology (JSMO2026) will take place from March 26–28, 2026, at PACIFICO Yokohama North and Exhibition Hall D in Yokohama, Japan. Centered on the theme “Medical Oncologists for Cancer Patients,” this year’s meeting marks the 20th anniversary of JSMO’s board certification program and offers a timely […]
The Summit on Cancer Health Disparities (SCHD26) is a two-day conference organized by Binaytara, scheduled for March 27–28, 2026, at the Hyatt Regency Bellevue in Bellevue, Washington, United States. This summit is dedicated to addressing the critical issue of cancer health disparities. Attendees can earn up to 12.75 credits, and the conference is designed to […]
The public meeting, "Application of External Control Arms in Oncology Drug Development," hosted by Friends of Cancer Research, is scheduled for Tuesday, April 7, 2026, from 10:00 AM to 2:00 PM ET, at The Ritz-Carlton in Washington, DC, with a virtual streaming option available. The purpose of the meeting is to explore opportunities for advancing […]